STEPAN CO (SCL) Stock Fundamental Analysis

NYSE:SCL • US8585861003

50.89 USD
-0.44 (-0.86%)
At close: Feb 27, 2026
50.89 USD
0 (0%)
After Hours: 2/27/2026, 8:04:00 PM
Fundamental Rating

4

Overall SCL gets a fundamental rating of 4 out of 10. We evaluated SCL against 83 industry peers in the Chemicals industry. Both the profitability and financial health of SCL have multiple concerns. SCL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • SCL had positive earnings in the past year.
  • In the past year SCL had a positive cash flow from operations.
  • In the past 5 years SCL has always been profitable.
  • SCL had a positive operating cash flow in 4 of the past 5 years.
SCL Yearly Net Income VS EBIT VS OCF VS FCFSCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • The Return On Assets of SCL (1.86%) is comparable to the rest of the industry.
  • SCL's Return On Equity of 3.63% is fine compared to the rest of the industry. SCL outperforms 60.24% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.55%, SCL is in line with its industry, outperforming 53.01% of the companies in the same industry.
Industry RankSector Rank
ROA 1.86%
ROE 3.63%
ROIC 3.55%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SCL Yearly ROA, ROE, ROICSCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • The Profit Margin of SCL (1.96%) is comparable to the rest of the industry.
  • SCL's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 3.29%, SCL is doing worse than 61.45% of the companies in the same industry.
  • In the last couple of years the Operating Margin of SCL has declined.
  • With a Gross Margin value of 11.94%, SCL is not doing good in the industry: 79.52% of the companies in the same industry are doing better.
  • SCL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.29%
PM (TTM) 1.96%
GM 11.94%
OM growth 3Y-26.77%
OM growth 5Y-20.39%
PM growth 3Y-27.63%
PM growth 5Y-21.58%
GM growth 3Y-9.08%
GM growth 5Y-10.82%
SCL Yearly Profit, Operating, Gross MarginsSCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SCL is destroying value.
  • There is no outstanding debt for SCL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SCL Yearly Shares OutstandingSCL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SCL Yearly Total Debt VS Total AssetsSCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 2.48 indicates that SCL is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.48, SCL is in the better half of the industry, outperforming 67.47% of the companies in the same industry.
  • SCL has a debt to FCF ratio of 20.43. This is a negative value and a sign of low solvency as SCL would need 20.43 years to pay back of all of its debts.
  • The Debt to FCF ratio of SCL (20.43) is comparable to the rest of the industry.
  • SCL has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
  • SCL's Debt to Equity ratio of 0.29 is fine compared to the rest of the industry. SCL outperforms 75.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 20.43
Altman-Z 2.48
ROIC/WACC0.31
WACC11.4%
SCL Yearly LT Debt VS Equity VS FCFSCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • SCL has a Current Ratio of 1.30. This is a normal value and indicates that SCL is financially healthy and should not expect problems in meeting its short term obligations.
  • SCL has a Current ratio of 1.30. This is amonst the worse of the industry: SCL underperforms 83.13% of its industry peers.
  • SCL has a Quick Ratio of 1.30. This is a bad value and indicates that SCL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SCL's Quick ratio of 0.84 is on the low side compared to the rest of the industry. SCL is outperformed by 77.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.84
SCL Yearly Current Assets VS Current LiabilitesSCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

  • The earnings per share for SCL have decreased strongly by -17.27% in the last year.
  • Measured over the past years, SCL shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -20.33% on average per year.
  • The Revenue has been growing slightly by 6.96% in the past year.
  • The Revenue has been growing slightly by 4.52% on average over the past years.
EPS 1Y (TTM)-17.27%
EPS 3Y-35.11%
EPS 5Y-20.33%
EPS Q2Q%-116.67%
Revenue 1Y (TTM)6.96%
Revenue growth 3Y-5.61%
Revenue growth 5Y4.52%
Sales Q2Q%5.38%

3.2 Future

  • The Earnings Per Share is expected to grow by 60.47% on average over the next years. This is a very strong growth
  • SCL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.88% yearly.
EPS Next Y95.06%
EPS Next 2Y60.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.14%
Revenue Next 2Y6.39%
Revenue Next 3Y7.13%
Revenue Next 5Y5.88%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SCL Yearly Revenue VS EstimatesSCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
SCL Yearly EPS VS EstimatesSCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 27.96 indicates a quite expensive valuation of SCL.
  • Compared to the rest of the industry, the Price/Earnings ratio of SCL is on the same level as its industry peers.
  • When comparing the Price/Earnings ratio of SCL to the average of the S&P500 Index (27.07), we can say SCL is valued inline with the index average.
  • The Price/Forward Earnings ratio is 14.33, which indicates a correct valuation of SCL.
  • Based on the Price/Forward Earnings ratio, SCL is valued a bit cheaper than the industry average as 67.47% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.05, SCL is valued a bit cheaper.
Industry RankSector Rank
PE 27.96
Fwd PE 14.33
SCL Price Earnings VS Forward Price EarningsSCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • SCL's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SCL is cheaper than 74.70% of the companies in the same industry.
  • SCL's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 35.89
EV/EBITDA 8.54
SCL Per share dataSCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SCL's earnings are expected to grow with 60.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.29
PEG (5Y)N/A
EPS Next 2Y60.47%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.08%, SCL has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 2.19, SCL pays a bit more dividend than its industry peers.
  • SCL's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.08%

5.2 History

  • On average, the dividend of SCL grows each year by 8.06%, which is quite nice.
  • SCL has been paying a dividend for at least 10 years, so it has a reliable track record.
  • SCL has decreased its dividend recently.
Dividend Growth(5Y)8.06%
Div Incr Years1
Div Non Decr Years1
SCL Yearly Dividends per shareSCL Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • SCL pays out 76.82% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of SCL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP76.82%
EPS Next 2Y60.47%
EPS Next 3YN/A
SCL Yearly Income VS Free CF VS DividendSCL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M
SCL Dividend Payout.SCL Dividend Payout, showing the Payout Ratio.SCL Dividend Payout.PayoutRetained Earnings

STEPAN CO

NYSE:SCL (2/27/2026, 8:04:00 PM)

After market: 50.89 0 (0%)

50.89

-0.44 (-0.86%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-23
Earnings (Next)04-27
Inst Owners86.79%
Inst Owner Change-2.09%
Ins Owners5.55%
Ins Owner Change5.11%
Market Cap1.15B
Revenue(TTM)2.33B
Net Income(TTM)45.24M
Analysts80
Price Target76.5 (50.32%)
Short Float %1.62%
Short Ratio1.87
Dividend
Industry RankSector Rank
Dividend Yield 3.08%
Yearly Dividend1.51
Dividend Growth(5Y)8.06%
DP76.82%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-02
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.76%
Min EPS beat(2)-42.79%
Max EPS beat(2)-22.72%
EPS beat(4)1
Avg EPS beat(4)-24.99%
Min EPS beat(4)-65.06%
Max EPS beat(4)30.63%
EPS beat(8)3
Avg EPS beat(8)-1.9%
EPS beat(12)4
Avg EPS beat(12)-8.59%
EPS beat(16)7
Avg EPS beat(16)-1.91%
Revenue beat(2)0
Avg Revenue beat(2)-1.57%
Min Revenue beat(2)-1.58%
Max Revenue beat(2)-1.55%
Revenue beat(4)1
Avg Revenue beat(4)0.44%
Min Revenue beat(4)-1.58%
Max Revenue beat(4)5.27%
Revenue beat(8)1
Avg Revenue beat(8)-2.38%
Revenue beat(12)2
Avg Revenue beat(12)-3.48%
Revenue beat(16)6
Avg Revenue beat(16)-0.7%
PT rev (1m)-11.76%
PT rev (3m)-11.76%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.14%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.85%
Valuation
Industry RankSector Rank
PE 27.96
Fwd PE 14.33
P/S 0.5
P/FCF 35.89
P/OCF 7.37
P/B 0.92
P/tB 1.04
EV/EBITDA 8.54
EPS(TTM)1.82
EY3.58%
EPS(NY)3.55
Fwd EY6.98%
FCF(TTM)1.42
FCFY2.79%
OCF(TTM)6.9
OCFY13.57%
SpS101.85
BVpS55.12
TBVpS48.93
PEG (NY)0.29
PEG (5Y)N/A
Graham Number47.51
Profitability
Industry RankSector Rank
ROA 1.86%
ROE 3.63%
ROCE 4.4%
ROIC 3.55%
ROICexc 3.82%
ROICexgc 4.18%
OM 3.29%
PM (TTM) 1.96%
GM 11.94%
FCFM 1.39%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-26.77%
OM growth 5Y-20.39%
PM growth 3Y-27.63%
PM growth 5Y-21.58%
GM growth 3Y-9.08%
GM growth 5Y-10.82%
F-Score4
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 20.43
Debt/EBITDA 1.81
Cap/Depr 101.87%
Cap/Sales 5.39%
Interest Coverage 2.64
Cash Conversion 79.05%
Profit Quality 70.9%
Current Ratio 1.3
Quick Ratio 0.84
Altman-Z 2.48
F-Score4
WACC11.4%
ROIC/WACC0.31
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.27%
EPS 3Y-35.11%
EPS 5Y-20.33%
EPS Q2Q%-116.67%
EPS Next Y95.06%
EPS Next 2Y60.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.96%
Revenue growth 3Y-5.61%
Revenue growth 5Y4.52%
Sales Q2Q%5.38%
Revenue Next Year8.14%
Revenue Next 2Y6.39%
Revenue Next 3Y7.13%
Revenue Next 5Y5.88%
EBIT growth 1Y6.39%
EBIT growth 3Y-30.88%
EBIT growth 5Y-16.79%
EBIT Next Year199.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y8.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.03%
OCF growth 3YN/A
OCF growth 5YN/A

STEPAN CO / SCL FAQ

What is the fundamental rating for SCL stock?

ChartMill assigns a fundamental rating of 4 / 10 to SCL.


Can you provide the valuation status for STEPAN CO?

ChartMill assigns a valuation rating of 5 / 10 to STEPAN CO (SCL). This can be considered as Fairly Valued.


Can you provide the profitability details for STEPAN CO?

STEPAN CO (SCL) has a profitability rating of 3 / 10.


What is the financial health of STEPAN CO (SCL) stock?

The financial health rating of STEPAN CO (SCL) is 3 / 10.


How sustainable is the dividend of STEPAN CO (SCL) stock?

The dividend rating of STEPAN CO (SCL) is 6 / 10 and the dividend payout ratio is 76.82%.